MarketCap
Facebook
X
TelegramQuarterly report 2026-Q3
added 05-20-2026
Haemonetics Corporation Cash and Cash Equivalents 2011-2026 | HAE
Annual Cash and Cash Equivalents Haemonetics Corporation
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 245 M | 307 M | 179 M | 284 M | 259 M | 192 M | 137 M | 169 M | 180 M | 140 M | 115 M | 161 M | 192 M | 179 M | 229 M | 197 M | 142 M | 157 M | 134 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 307 M | 115 M | 189 M |
Quarterly Cash and Cash Equivalents Haemonetics Corporation
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 363 M | 296 M | 293 M | 363 M | 296 M | 293 M | 307 M | 321 M | 299 M | 344 M | 179 M | 194 M | 351 M | 286 M | 284 M | 224 M | 241 M | 215 M | 259 M | - | 192 M | 173 M | 192 M | 189 M | 189 M | 279 M | 276 M | 126 M | 126 M | 112 M | 190 M | 155 M | 155 M | 200 M | 180 M | 252 M | 204 M | 172 M | 140 M | 130 M | 139 M | 118 M | 115 M | 105 M | 100 M | 112 M | 161 M | 125 M | 130 M | 140 M | 192 M | 178 M | 159 M | 166 M | 179 M | 193 M | 187 M | 236 M | 229 M | 205 M | 183 M | 217 M | 197 M | 170 M | 115 M | 83.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 363 M | 83.5 M | 203 M |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
111 M | $ 67.67 | -1.39 % | $ 13.5 B | USA |
 |
Glaukos Corporation
GKOS
|
90.8 M | $ 122.47 | -3.14 % | $ 7 B | USA |
 |
Intuitive Surgical
ISRG
|
3.37 B | $ 413.89 | -2.98 % | $ 148 B | USA |
 |
Alcon
ALC
|
1.53 B | $ 66.2 | -2.5 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
308 M | $ 141.02 | -0.69 % | $ 3.47 B | USA |
 |
iRhythm Technologies
IRTC
|
236 M | $ 113.59 | -0.21 % | $ 3.64 B | USA |
 |
Repro Med Systems
KRMD
|
8.87 M | $ 3.97 | -0.88 % | $ 183 M | USA |
 |
LeMaitre Vascular
LMAT
|
28.2 M | $ 92.67 | -4.06 % | $ 2.1 B | USA |
 |
Masimo Corporation
MASI
|
178 M | $ 179.95 | - | $ 9.59 B | USA |
 |
Microbot Medical
MBOT
|
3.91 M | $ 1.8 | -1.1 % | $ 82.4 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
1.17 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
1.11 M | $ 0.38 | -0.96 % | $ 31.2 M | USA |
 |
Merit Medical Systems
MMSI
|
446 M | $ 66.73 | -1.16 % | $ 3.95 B | USA |
 |
electroCore
ECOR
|
7.04 M | $ 10.03 | 5.3 % | $ 85.1 K | USA |
 |
Envista Holdings Corporation
NVST
|
1.21 B | $ 24.16 | -1.75 % | $ 4.06 B | USA |
 |
STERIS plc
STE
|
440 M | $ 206.71 | -2.9 % | $ 20.3 B | USA |
 |
Isoray
ISR
|
30.6 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
153 M | $ 29.46 | -1.39 % | $ 1.46 B | USA |
 |
InfuSystem Holdings
INFU
|
3.19 M | $ 8.9 | -1.22 % | $ 184 M | USA |
 |
Teleflex Incorporated
TFX
|
379 M | $ 132.31 | -2.53 % | $ 5.9 B | USA |
 |
Utah Medical Products
UTMD
|
85.8 M | $ 69.0 | 1.37 % | $ 224 M | USA |
 |
West Pharmaceutical Services
WST
|
791 M | $ 332.01 | -0.87 % | $ 24 B | USA |
 |
Pulse Biosciences
PLSE
|
80.7 M | $ 24.97 | -3.1 % | $ 1.68 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
326 M | $ 10.12 | -3.39 % | $ 2.02 B | USA |
 |
Retractable Technologies
RVP
|
2.59 M | $ 0.7 | 1.0 % | $ 21 M | USA |
 |
Pro-Dex
PDEX
|
419 K | $ 62.32 | -4.12 % | $ 205 M | USA |
 |
Predictive Oncology
POAI
|
10.8 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
33 M | $ 26.8 | -2.72 % | $ 1.28 B | USA |
 |
Stereotaxis
STXS
|
13.4 M | $ 1.83 | -1.35 % | $ 166 M | USA |
 |
Baxter International
BAX
|
1.97 B | $ 20.47 | 2.2 % | $ 10.5 B | USA |
 |
ResMed
RMD
|
274 M | $ 194.63 | -1.17 % | $ 28.4 B | USA |
 |
AtriCure
ATRC
|
167 M | $ 27.4 | 0.37 % | $ 1.31 B | USA |
 |
Harvard Bioscience
HBIO
|
8.61 M | $ 6.2 | 2.65 % | $ 275 M | USA |
 |
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
55.9 M | $ 12.31 | -0.28 % | $ 503 M | USA |
 |
Becton, Dickinson and Company
BDX
|
641 M | $ 148.35 | -2.43 % | $ 42.7 B | USA |
 |
Nephros
NEPH
|
5.4 M | $ 3.24 | -0.31 % | $ 34.4 M | USA |
 |
OraSure Technologies
OSUR
|
199 M | $ 4.04 | -4.83 % | $ 297 M | USA |
 |
Repligen Corporation
RGEN
|
566 M | $ 131.57 | 1.1 % | $ 7.4 M | USA |